EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Historical Holders from Q3 2019 to Q3 2025

Symbol
XGN on Nasdaq
CUSIP
30068X103
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
21.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
9.05M
Holdings value
$99.5M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
62
Number of buys
42
Number of sells
-21
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NMSIC Co-Investment Fund, L.P. 9.83% -17.8% $10.3M -$2.05M 1.76M -16.6% NMSIC Co-Investment Fund, L.P. Mar 25, 2025
RTW INVESTMENTS, LP 7.7% $11.6M 1.7M RTW Investments, LP Jun 30, 2025
Cowen Financial Products LLC 5% $5.21M 891K Cowen Financial Products LLC Mar 31, 2025
LYTTON LAURENCE W 1% $1.48M 217K LYTTON LAURENCE W Jun 30, 2025

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 9.05M $99.5M +$1.74M $10.99 62
2025 Q2 9.11M $63.6M +$21.4M $6.98 52
2025 Q1 6.24M $22.4M +$385K $3.59 38
2024 Q4 6.11M $25.1M -$538K $4.10 40
2024 Q3 6.39M $19.8M +$369K $3.09 33
2024 Q2 6.29M $11.4M +$147K $1.82 32
2024 Q1 6.2M $9.87M -$619K $1.59 30
2023 Q4 6.59M $13.1M -$540K $1.99 30
2023 Q3 6.87M $16.7M -$40.2K $2.42 29
2023 Q2 6.88M $20M +$147K $2.90 28
2023 Q1 6.83M $16.6M -$245K $2.43 27
2022 Q4 6.94M $16.6M -$2.31M $2.40 30
2022 Q3 7.86M $21.3M -$232M $2.71 36
2022 Q2 10.7M $277M -$6.86M $5.74 43
2022 Q1 9.09M $73M +$3.57M $8.03 55
2021 Q4 8.6M $100M -$2.77M $11.63 52
2021 Q3 8.78M $120M +$1.31M $13.60 53
2021 Q2 8.61M $129M -$7.05M $14.99 54
2021 Q1 8.95M $156M +$75.9M $17.50 57
2020 Q4 4.25M $56M +$2.49M $13.20 34
2020 Q3 4.28M $47M +$8.1M $10.84 33
2020 Q2 3.61M $44.7M -$5.87M $12.40 32
2020 Q1 3.87M $61.8M -$14M $15.94 32
2019 Q4 3.85M $97.7M +$14.4M $25.40 36
2019 Q3 3.58M $55.5M +$55.5M $15.49 27